Back
PTC Therapeutics, Inc. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Sell
43
PTCT
PTC Therapeutics, Inc.
Last Price:
$76.72
Seasonality Move:
5.57%
Sell
48
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$59.46
Seasonality Move:
8.88%
Sell
43
PTC Therapeutics, Inc. (PTCT)
is a Sell
Is PTC Therapeutics, Inc. a Buy, Sell or Hold?
-
The current PTC Therapeutics, Inc. [PTCT] share price is $75.96. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $59.43. The Score for BMRN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTCT Stock Price Chart
What is PTC Therapeutics, Inc.'s stock price today?
-
The PTC Therapeutics, Inc. share price today is $75.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $59.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.2 | Buy |
| Relative Strength Index (14 RSI): | 48.6 | Sell |
| Chaikin Money Flow: | -449768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.54 - 80.86) | Sell |
| Bollinger Bands (100): | (55.91 - 76.53) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.62 | Buy |
| Relative Strength Index (14 RSI): | 61.35 | Buy |
| Chaikin Money Flow: | 773444 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.54 - 58.9) | Buy |
| Bollinger Bands (100): | (52.66 - 57.5) | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.74 | Sell |
| 20-day SMA: | 76.48 | Sell |
| 50-day SMA: | 74.67 | Buy |
| 200-day SMA: | 57.41 | Buy |
| 8-day EMA: | 70.83 | Buy |
| 20-day EMA: | 48.81 | Buy |
| 50-day EMA: | 25.44 | Buy |
| 200-day EMA: | 7.34 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.02 | Sell |
| 20-day SMA: | 55.82 | Buy |
| 50-day SMA: | 54.6 | Buy |
| 200-day SMA: | 57.55 | Buy |
| 8-day EMA: | 58.79 | Buy |
| 20-day EMA: | 56.91 | Buy |
| 50-day EMA: | 55.5 | Buy |
| 200-day EMA: | 58.39 | Buy |
PTC Therapeutics, Inc. Earnings Growth & PTCT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.66 per share, and an increase next year of $1.72 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.48 per share.
PTC Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||